Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Colobomatous microphthalmia-rhizomelic dysplasia syndrome is a rare, genetic developmental defect during embryogenesis characterized by a range of developmental eye anomalies (including anophthalmia, microphthalmia, colobomas, microcornea, corectopia, cataract) and symmetric limb rhizomelia with short stature and contractures of large joints. Intellectual disability with autistic features, macrocephaly, dysmorphic features, urogenital anomalies (hypospadia, cryptorchidism), cutaneous syndactyly and precocious puberty may also be present.
Data assembled from 7 of 12 sources · Last updated Sep 21, 2026, 12:28 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about colobomatous microphthalmia-rhizomelic dysplasia syndrome
Features include common findings: Moderate intellectual disability, Rhizomelia, Strabismus, and Microcornea and others; and sometimes findings: 3-4 finger cutaneous syndactyly, Epicanthus, Long philtrum, and Cryptophthalmos and others. 24 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 3 | Strabismus, Cataract, Nystagmus |
Arms and legs | 2 | 3-4 finger cutaneous syndactyly, 2-3 toe syndactyly |
Brain and nerves | 1 | Moderate intellectual disability |
Head and neck | 1 | Macrocephaly |
Hormones | 1 | Precocious puberty |
MAB21L2 encodes mab-21 like 2 (359 aa). Required for several aspects of embryonic development including normal development of the eye Highest expression in Colon Sigmoid (340.7 TPM) and Colon Transverse (109.7 TPM).
Colobomatous microphthalmia-rhizomelic dysplasia syndrome is caused by mutations in the MAB21L2 gene on chromosome 4.
MAB21L2 is classified as a druggable target with score 0.0.
Genetic testing for MAB21L2 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for colobomatous microphthalmia-rhizomelic dysplasia syndrome has been reported in the published literature.
Phenotype severity distribution: 8 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for colobomatous microphthalmia-rhizomelic dysplasia syndrome.
121 publications have been identified in PubMed for colobomatous microphthalmia-rhizomelic dysplasia syndrome. Research spans Review / Meta-Analysis (32%), Basic Science / Preclinical (23%), and Case Report / Case Series (17%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 39 | 32% |
Laboratory research | 28 | 23% |
Patient case studies | 21 | 17% |
Disease patterns and progression | 17 | 14% |
Testing and diagnosis research | 8 | 7% |
Clinical study results | 4 | 3% |
New treatment approaches | 4 | 3% |
Farhan H (2026). [PMID: 40645854](https://pubmed.ncbi.nlm.nih.gov/40645854/). *Trends Mol Med*. [Review / Meta-Analysis]
Nevarez L (2026). [PMID: 41574606](https://pubmed.ncbi.nlm.nih.gov/41574606/). *JCI Insight*. [Basic Science / Preclinical]
Hoover-Fong J (2026). [PMID: 41504382](https://pubmed.ncbi.nlm.nih.gov/41504382/). *J Bone Miner Res*. [Clinical Trial Publication]
Pfirrmann C (2026). [PMID: 40998114](https://pubmed.ncbi.nlm.nih.gov/40998114/). *Orthop Traumatol Surg Res*. [Review / Meta-Analysis]
Wu X (2026). [PMID: 41713676](https://pubmed.ncbi.nlm.nih.gov/41713676/). *J Genet Genomics*. [Review / Meta-Analysis]
Lyu B (2026). [PMID: 41529958](https://pubmed.ncbi.nlm.nih.gov/41529958/). *Cell Calcium*. [Review / Meta-Analysis]
Tomatsu S (2026). [PMID: 42144266](https://pubmed.ncbi.nlm.nih.gov/42144266/). *J Inherit Metab Dis*. [Review / Meta-Analysis]
Millán JL (2026). [PMID: 41055578](https://pubmed.ncbi.nlm.nih.gov/41055578/). *J Bone Miner Res*. [Review / Meta-Analysis]
Weaver KN (2026). [PMID: 42157491](https://pubmed.ncbi.nlm.nih.gov/42157491/). *HGG Adv*. [Basic Science / Preclinical]
Wang L (2026). [PMID: 41457519](https://pubmed.ncbi.nlm.nih.gov/41457519/). *Ann Med*. [Basic Science / Preclinical]